Japanese drugmaker Santen Pharmaceutical said on Wednesday it has agreed to buy 50.55 percent of French eye care company Novagali from its main shareholders, followed by a tender offer for the rest of the company. Novagali shareholders IdInvest Partners have agreed to sell their shares at a 71.3 percent premium...